Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangdong Kanghua Healthcare Group CoFRA:E9Q 82 Return-on-Tangible-Equity is 8.69% as of Dec. 2025, which is 18% above its 10-year median of 7.37. GuruFocus rates FRA:E9Q with a GF Score™ of 82/100 and a GF Value™ of €0.19. The stock has 1 warning sign investors should review. Among 576 Healthcare Providers & Services companies, Guangdong Kanghua Healthcare Group Co ranks worse than 57.29% on this metric.
The historical rank and industry rank for Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity or its related term are showing as below:
FRA:E9Q'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -2.07 Med: 7.37 Max: 20.13
Current: 7.6
During the past 13 years, Guangdong Kanghua Healthcare Group Co's highest Return-on-Tangible-Equity was 20.13%. The lowest was -2.07%. And the median was 7.37%.
FRA:E9Q's Return-on-Tangible-Equity is ranked worse than 57.29% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs FRA:E9Q: 7.60
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Guangdong Kanghua Healthcare Group Co Return-on-Tangible-Equity Related Terms
Guangdong Kanghua Healthcare Group Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co Return-on-Tangible-Equity Chart
FRA:E9Q vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.69% mean?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a Return-on-Tangible-Equity of 8.69% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. This is 18% above median its historical median of 7.37. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #330 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 57.3%.
Is Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity too high?
Guangdong Kanghua Healthcare Group Co's current Return-on-Tangible-Equity of 8.69% is 18% above median its 10-year median of 7.37. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Guangdong Kanghua Healthcare Group Co's value of 8.69% is 14.6% below this industry median. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #330 out of 576 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #330 out of 576 companies for Return-on-Tangible-Equity. This places Guangdong Kanghua Healthcare Group Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Guangdong Kanghua Healthcare Group Co's value of 8.69% is 14.6% below this benchmark. While the company's 10-year median is 7.37 vs. the industry median of 10.17, Guangdong Kanghua Healthcare Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Kanghua Healthcare Group Co's current Return-on-Tangible-Equity of 8.69% is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current Return-on-Tangible-Equity is 8.69%, which is 18% above median its own 10-year median of 7.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current Return-on-Tangible-Equity of 8.69%. The stock's GF Value™ is €0.19, compared to a current price of €0.18 — trading 4.2% below its estimated fair value. The current Return-on-Tangible-Equity is 8.69%, which is 18% above median its 10-year median of 7.37 and 14.6% below the Healthcare Providers & Services industry median of 10.17. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current Return-on-Tangible-Equity is 8.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.18 is trading 4.2% below its estimated GF Value™ of €0.19.
Key valuation signals for FRA:E9Q:
Return-on-Tangible-Equity: 8.69% (18% above median its 10-year median of 7.37)
GF Value™: €0.19 vs. price of €0.18 (4.2% below fair value)
Industry Position: 14.6% below the Healthcare Providers & Services median (#330 of 576)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Business Description
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
82GF Score
Get the complete analysis for FRA:E9Q
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
